[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=80311]], camposKey:1424-8247 2023-04-01 Trends in the Use of Driving-Impairing Medicines According to the DRUID Category: A Population-Based Registry Study with Reference to Driving in a Region of Spain between 2015 and 201900, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75667]], camposKey:0003-4975 2023-02-01 Role of PARTNER 3 in the Surgical Approach552553, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65058]], camposKey:1364-8535 2022-12-01 Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75668]], camposKey:1999-4923 2022-12-01 Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=68805]], camposKey:1010-660X 2022-06-01 Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82891]], camposKey:2308-3425 2021-12-01 A population-based registry analysis on hospitalized covid-19 patients with previous cardiovascular disease: Clinical profile, treatment, and predictors of death00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82893]], camposKey:2296-858X 2021-06-15 Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58801]], camposKey:0014-2972 2021-06-01 Aortic endocarditis as a possible long-term prognostic factor in surgical aortic valve replacement00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58802]], camposKey:1661-7827 2021-05-02 Positivity to cocaine and/or benzoylecgonine in confirmation analyses for on-road tests in spain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61689]], camposKey:2296-858X 2021-01-01 Binding Potassium to Improve Treatment With Renin-Angiotensin-Aldosterone System Inhibitors: Results From Multiple One-Stage Pairwise and Network Meta-Analyses of Clinical Trials00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58803]], camposKey:0767-3981 2021-01-01 Trends in the use of antihistamines with reference to drivers between 2015 and 2019: A population-based registry analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58793]], camposKey:0214-3429 2020-12-01 Trend in the use of topical ocular anti-infectives in a region of Spain between 2015 and 2019: a population-based registry study453458, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=82894]], camposKey:1424-8247 2020-08-01 Population-based registry analysis of antidiabetics dispensations: Trend use in Spain between 2015 and 2018 with reference to driving112, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52139]], camposKey:1747-597X 2020-01-01 Benzodiazepines in the oral fluid of Spanish drivers00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58804]], camposKey:1661-7827 2020-01-01 Clinical profile, treatment and predictors during the first covid-19 wave: A population-based registry analysis from castile and leon hospitals115, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58805]], camposKey:0003-4975 2020-01-01 Is Hemoadsorption a Really Necessary Treatment in Endocarditis Surgery?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55558]], camposKey:0379-0738 2020-01-01 Prevalence of alcohol and other psychoactive substances in motor vehicle drivers in Spain, 2018: Cross-sectional dataset analysis with studies from 2008 and 201300, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=77897]], camposKey:2227-9059 2020-01-01 ¿The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies¿.3550, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=55560]], camposKey:1424-8247 2020-01-01 Trends in antidepressants use in Spain between 2015 and 2018: Analyses from a population-based registry study with reference to driving00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52137]], camposKey:0001-4575 2020-01-01 Worldwide research output trends on drinking and driving from 1956 to 201500, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58794]], camposKey:2077-0383 2019-01-01 A New Surgical Site Infection Risk Score: Infection Risk Index in Cardiac Surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49045]], camposKey:0268-1315 2019-01-01 Antipsychotics in the general population and the driver population: comparisons from a population-based registry study184188, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49056]], camposKey:2045-2322 2019-01-01 Cholesterol-Lowering Treatment in Chronic Kidney Disease: Multistage Pairwise and Network Meta-Analyses00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49057]], camposKey:2044-6055 2019-01-01 Drivers who tested positive for cannabis in oral fluid: A longitudinal analysis of administrative data for Spain between 2011 and 201600, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58795]], camposKey:0211-6995 2019-01-01 Potentially inapropriate prescribing in patients on dialysis using STOPP-START criteria9294, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=52138]], camposKey:2077-0383 2019-01-01 The Trends in Opioid Use in Castile and Leon, Spain: A Population-Based Registry Analysis of Dispensations in 2015 to 201800, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49023]], camposKey:0214-4840 2019-01-01 What to do when drivers test positive for methadone in roadside drug tests? The Spanish Experience ¿Que hacer en los casos que dan positivo a metadona en los controles de drogas en carretera? La experiencia de España324326, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58797]], camposKey:1353-8047 2018-11-01 CANNABIS IN ORAL FLUID OF SPANISH DRIVERS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58796]], camposKey:1353-8047 2018-11-01 METHADONE IN ORAL FLUID OF SPANISH DRIVERS00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=61699]], camposKey:2077-0383 2018-01-01 Correction of hyponatremia may be a treatment stratification biomarker: A two-stage systematic review and meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49058]], camposKey:2352-3409 2018-01-01 Data on a new biomarker for kidney transplant recipients: The number of FoxP3 regulatory T cells in the circulation25672575, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37970]], camposKey:0376-8716 2018-01-01 Opioids in oral fluid of Spanish drivers3539, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49024]], camposKey:1567-5769 2018-01-01 The number of FoxP3 regulatory T cells in the circulation may be a predictive biomarker for kidney transplant recipients: A multistage systematic review483492, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=37971]], camposKey:1663-9812 2018-01-01 The problem of benzodiazepine use and its extent in the driver population: A population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=17252]], camposKey:1886-2845 2017-01-01 Correlaciones clínicas de los recuentos en sangre periférica de células T reguladoras en el post-trasplante renal8291, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=30495]], camposKey:1663-9812 2017-01-01 Effects of intensive control of glycemia on clinical kidney outcomes in type 2 diabetes patients compared with standard control: A meta-analysis00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58798]], camposKey:0025-7753 2017-01-01 Peripheral blood regulatory T cell counts as a predictive biomarker for the outcome of kidney transplant: A systematic review523535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23323]], camposKey:0025-7753 2017-01-01 Recuentos de células T reguladoras en sangre periférica como biomarcador predictivo del resultado del trasplante renal: revisión sistemática523535, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=23320]], camposKey:1886-2845 2017-01-01 ¿Son los recuentos de células T reguladoras en sangre periférica un biomarcador predictivo y pronóstico para mejorar los resultados en el trasplante renal? Una revisión sistemática4056, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=49047]], camposKey:2044-6055 2017-01-01 Use of driving-impairing medicines by a Spanish population: a population-based registry study00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58799]], camposKey:0211-6995 2016-01-01 Blanket orders, an unadvisable practise, yet more and more frequent718719, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58800]], camposKey:0211-6995 2016-01-01 Degree of adherence and knowledge prior to medication reconciliation in patients on peritoneal dialysis459460, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=58792]], camposKey:0248-8663 2008-05-01 A huge hypergammaglobulinemia. Visceral leishmaniasis408409][CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=31126]},camposKey: 601 606 Autoevaluación y prácticas de farmacología en el Grado de Medicina: Tensión arterial 978-84-124511-6-0Conference proceedings. CIVINEDU 2022: 6th International Virtual Conference on Educational Research and Innovation 1 2022-01-01 REDINE (Red de Investigación e Innovación Educativa) , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26782]},camposKey: 449 453 Utilización de "Píldoras de Conocimiento" para la innovación docente en farmacología 978-84-124511-1-5Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation 1 2021-01-01 Adaya Press , CapitolsLlib{id=com.sigma.fs3.argos.domain.gpc.GpcCapitolsLlibPK[ifcactivitat=CAP, ifccomptador=26783]},camposKey: 430 435 Utilización de programas de simulación informática en la enseñanza práctica de farmacología 978-84-124511-1-5Conference proceedings. CIVINEDU 2021: 5th International Virtual Conference onEducational Research and Innovation 1 2021-01-01 Adaya Press ][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31192]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=31080]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30981]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30558]], com.sigma.fs3.argos.domain.gpc.GpcTesis[id=com.sigma.fs3.argos.domain.gpc.GpcTesisPK[ifcactivitat=TES, ifccomptador=30425]]][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@dc9a07a, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@5f449c3f, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@6508f2a0, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@44f8eaed, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@4f24878, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7f2c89bd][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64dac2, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64dbde, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@64d775][][][][][][][][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@175b8, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@176cf, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17a83, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@17055, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15d86, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@15d77, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@16158, com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@151ec][]